Published in BMC Infect Dis on June 05, 2014
Clinical features and outcome of mucormycosis. Interdiscip Perspect Infect Dis (2014) 0.77
Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study. BMC Infect Dis (2016) 0.77
Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013. Open Forum Infect Dis (2017) 0.75
Comorbidity measures for use with administrative data. Med Care (1998) 46.67
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med (1998) 32.43
Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis (2005) 13.97
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis (2009) 4.19
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis (2009) 1.62
Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm (2009) 1.44
Healthcare-associated mucormycosis. Clin Infect Dis (2012) 1.42
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis (2011) 1.34
Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother (2009) 1.31
Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009. Antimicrob Agents Chemother (2011) 1.04
Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant (2009) 0.89
Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options. Pharmacotherapy (2012) 0.86
Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? Med Mycol (2009) 0.84
Epidemiology of mucormycosis in Europe. Clin Microbiol Infect (2014) 0.82
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97
Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations. Crit Care Med (2006) 4.85
Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med (2004) 3.97
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88
Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med (2012) 3.86
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis (2011) 3.78
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol (2003) 3.46
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20
Blood transfusion and nosocomial infection: another brick in the wall. Crit Care Med (2006) 3.00
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest (2006) 2.73
Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients. Crit Care Med (2012) 2.65
Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery. Crit Care Med (2008) 2.43
Ethical assessment of industry-sponsored clinical trials: a case analysis. Chest (2002) 2.27
Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion (2010) 2.24
Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest (2005) 2.20
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med (2005) 2.12
Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: a retrospective analysis. J Crit Care (2012) 2.09
Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest (2009) 2.09
Z-score reference ranges for normal fetal heart sizes throughout pregnancy derived from fetal echocardiography. Prenat Diagn (2014) 1.98
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect (2010) 1.83
Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest (2010) 1.81
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74
Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med (2014) 1.61
Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis (2013) 1.60
Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids (2007) 1.59
Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol (2009) 1.58
Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med (2008) 1.58
Accuracy of previous estimates for adult prolonged acute mechanical ventilation volume in 2020: update using 2000-2008 data. Crit Care Med (2012) 1.57
Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United States. Crit Care Med (2008) 1.50
Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis. Respiration (2004) 1.48
Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest (2008) 1.47
Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest (2009) 1.47
Growth in dementia-associated hospitalizations among the oldest old in the United States: implications for ethical health services planning. Arch Intern Med (2011) 1.46
Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. Infect Control Hosp Epidemiol (2013) 1.45
Unnecessary use of placebo controls: the case of asthma clinical trials. Arch Intern Med (2002) 1.44
Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Respiration (2004) 1.44
The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort Study. Chest (2015) 1.43
Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol (2008) 1.42
Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis (2009) 1.39
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis (2010) 1.29
Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med (2006) 1.25
FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials. Clin Infect Dis (2014) 1.25
Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin (2008) 1.23
Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning. BMC Health Serv Res (2008) 1.23
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis (2011) 1.22
Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis (2010) 1.21
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med (2007) 1.21
Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med (2002) 1.20
Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J (2008) 1.20
Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun (2005) 1.15
Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care (2007) 1.14
Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis (2008) 1.10
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis. Crit Care (2011) 1.09
Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun (2004) 1.08
Antimicrobial stewardship: shepherding precious resources. Am J Health Syst Pharm (2009) 1.08
An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma (2009) 1.08
Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07
Mitigating VTE in soldiers from Operation Iraqi Freedom and Operation Enduring Freedom. Chest (2014) 1.07
Assessment of reporting bias for Clostridium difficile hospitalizations, United States. Emerg Infect Dis (2008) 1.05
Glucose directly links to lipid metabolism through high affinity interaction with peroxisome proliferator-activated receptor alpha. J Biol Chem (2007) 1.05
Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes. Arch Biochem Biophys (2009) 1.05
Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulm Med (2008) 1.05
Hepatic phenotype of liver fatty acid binding protein gene-ablated mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.04
Fluorescence techniques using dehydroergosterol to study cholesterol trafficking. Lipids (2008) 1.03
Development and validation of a mortality risk-adjustment model for patients hospitalized for exacerbations of chronic obstructive pulmonary disease. Med Care (2013) 1.03
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis (2013) 1.03
Ablation of the liver fatty acid binding protein gene decreases fatty acyl CoA binding capacity and alters fatty acyl CoA pool distribution in mouse liver. Biochemistry (2003) 1.03
Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J Neuroimmunol (2002) 1.02
Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med (2009) 1.01
Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med (2009) 1.01
Role of protein kinase A in Trypanosoma cruzi. Infect Immun (2008) 1.00
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med (2010) 1.00
Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections. BMC Infect Dis (2012) 1.00
Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int J Parasitol (2002) 0.99
Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. J Hosp Med (2010) 0.99
Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol (2009) 0.99
Glucose regulates fatty acid binding protein interaction with lipids and peroxisome proliferator-activated receptor α. J Lipid Res (2010) 0.99
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care (2013) 0.99
Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int J Parasitol (2002) 0.98
Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis (2010) 0.98
Venous thromboembolic disease in the intensive care unit. Semin Respir Crit Care Med (2010) 0.98
Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism. Mol Cell Biochem (2004) 0.97
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. Clin Infect Dis (2008) 0.97
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation. Crit Care (2009) 0.97
Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology. J Crit Care (2010) 0.96
The protein C pathway: implications for the design of the RESPOND study. Crit Care (2007) 0.96
Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors. Infect Control Hosp Epidemiol (2009) 0.96
The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome. J Crit Care (2011) 0.96
Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study. Crit Care (2008) 0.95
Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med (2009) 0.95
Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol Res (2004) 0.94
Trypanosoma cruzi induces changes in cardiac connexin43 expression. Microbes Infect (2007) 0.94
Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis. Folia Parasitol (Praha) (2005) 0.94
Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect Immun (2006) 0.94